American Society of Clinical Oncology Annual Meeting 2023 Conference Highlight: Phase 1/2a Study of PRL-02, a Long-Acting Intramuscular Depot Injection of Abiraterone Decanoate, in Patients with Advanced Prostate Cancer

Click here for UrologyToday.com’s ASCO 2023 Conference Highlight titled “ASCO 2023: Phase 1/2a Study of PRL-02, a Long-Acting Intramuscular Depot Injection of Abiraterone Decanoate, in Patients with Advanced Prostate Cancer.”